Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene

journal article published in 1989

Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/JAPPL.1989.67.6.2542
P8608Fatcat IDrelease_iriiks3qcbaclm5vxx7lrt3gme
P953full work available at URLhttp://jap.physiology.org/cgi/content/abstract/67/6/2542
P2880NIOSHTIC-2 ID00193658
P698PubMed publication ID2558103

P2093author name stringC Hopkins
A M Sciuto
G H Gurtner
J R Michael
T P Kennedy
E Tolley
J R Hoidal
D Hasty
G K Bysani
R Lazar
P6195funding schemegrantQ230788
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpulmonary edemaQ857667
list of highly toxic gasesQ2263216
respiratory diseaseQ3286546
phosgeneQ189090
lung diseaseQ3392853
occupational lung diseaseQ7075805
P5008on focus list of Wikimedia projectWikimedia–NIOSH collaborationQ104416361
P304page(s)2542-52
P12526performing organizationUniversity of Tennessee Health Science CenterQ7896420
P577publication date1989-12-01
P1433published inJournal of Applied PhysiologyQ1091719
P859sponsorNational Institute for Occupational Safety and HealthQ60346
P1476titleDibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene
P478volume67

Reverse relations

cites work (P2860)
Q44018762Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene
Q35938701Acute lung injury after phosgene inhalation
Q44689954Adenosine modulates vascular resistance and fluid filtration in isolated rat lungs
Q52514509Adenosine protects ultrastructure of isolated rat lungs against fat emulsion injury.
Q46474681Attenuation of LPS-induced neutrophil thromboxane B2 release and chemiluminescence
Q46164473Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence
Q36484322Clinical management of casualties exposed to lung damaging agents: a critical review
Q38420382Conceptual approaches for treatment of phosgene inhalation-induced lung injury.
Q36015327Defining the phosphodiesterase superfamily members in rat brain microvessels
Q74219229Dibutylyl cyclic adenosine monophosphate attenuates damage in the ultrastructure of endothelial cells in 15-hour cold preserved rat lungs
Q73807558Dibutyryl cyclic adenosine monophosphate attenuates lung injury caused by cold preservation and ischemia-reperfusion
Q43186150Early treatment with nebulised salbutamol worsens physiological measures and does not improve survival following phosgene induced acute lung injury
Q31948108Effect of dietary treatment with n-propyl gallate or vitamin E on the survival of mice exposed to phosgene
Q77101725Effect of preischemic catecholamine treatment on ischemia-reperfusion injury of the myocardium: subtype, dose, and temperature dependency
Q39327987Evaluation of an in vitro screening model to assess phosgene inhalation injury
Q34263355Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron
Q74217148In vitro adduct formation of phosgene with albumin and hemoglobin in human blood
Q78242231Is the use of catecholamine before ischemic arrest safe? Effect of catecholamine on rat heart ischemia/reperfusion injury
Q37789760Management of phosgene-induced acute lung injury
Q28369563Mechanisms underlying enhanced responses of J receptors of cats to excitants in pulmonary oedema
Q34695957Microbiological, biological, and chemical weapons of warfare and terrorism
Q67690110Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP
Q36738993Phosgene effects on F-actin organization and concentration in cells cultured from sheep and rat lung
Q30407772Phosgene exposure: a case of accidental industrial exposure
Q32066461Phosgene exposure: mechanisms of injury and treatment strategies
Q73458185Postexposure treatment with aminophylline protects against phosgene-induced acute lung injury
Q46821949Posttreatment with eicosatetraynoic acid decreases lung edema in guinea pigs exposed to phosgene: the role of leukotrienes
Q71596856Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP
Q43981329Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Q40304072Role of phosphodiesterases in the regulation of endothelial permeability in vitro
Q40444772Role of the lung in accumulation and metabolism of xenobiotic compounds--implications for chemically induced toxicity
Q33712167The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment
Q35809694Therapeutic treatments of phosgene-induced lung injury
Q39468819Toxic effects following phosgene exposure of human epithelial lung cells in vitro using a CULTEX® system
Q46865431Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance
Q43505285beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury.

Search more.